Tatva Chintan Pharma Chem Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 110.55 | 108.94 | 84.04 |
| Operating Expense | 94.11 | 99.75 | 78.35 |
| Net Profit | 5.13 | 1.10 | -1.17 |
| Net Profit Margin | 4.64 | 1.01 | -1.39 |
| Earning Per Share | 2.19 | 0.47 | -0.50 |
| EBIDTA | 15.72 | 8.74 | 6.11 |
| Effective Tax Rate | 7.36 | -0.11 | -1.05 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 110.55 |
| Operating Expense | 94.11 |
| Net Profit | 5.13 |
| Net Profit Margin | 4.64 |
| Earning Per Share | 2.19 |
| EBIDTA | 15.72 |
| Effective Tax Rate | 7.36 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 366.42 | 378.68 | 403.04 |
| Operating Expenses Annual | 340.57 | 311.81 | 348.37 |
| Operating Profit Annual | 29.41 | 74.37 | 56.77 |
| Interest Annual | 1.29 | 6.51 | 8.38 |
| Depreciation | 26.52 | 25.15 | 9.16 |
| Net Profit Annual | 0.33 | 29.35 | 40.47 |
| Tax Annual | 0.13 | 12.92 | -1.63 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 366.42 |
| Operating Expenses Annual | 340.57 |
| Operating Profit Annual | 29.41 |
| Interest Annual | 1.29 |
| Depreciation | 26.52 |
| Net Profit Annual | 0.33 |
| Tax Annual | 0.13 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 33.99 | 21.19 | 60.78 |
| Cash Flow from Operations | 23.91 | 102.78 | 23.73 |
| Cash Flow from Investing | -65.25 | -120.52 | -101.13 |
| Cash Flow from Financing | 16.57 | 30.54 | 37.82 |
| Cash Flow at the End | 9.21 | 33.99 | 21.19 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 33.99 |
| Cash Flow from Operations | 23.91 |
| Cash Flow from Investing | -65.25 |
| Cash Flow from Financing | 16.57 |
| Cash Flow at the End | 9.21 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 8.07 | 19.68 | 14.12 |
| PBIT Margin (%) | 0.52 | 12.92 | 11.75 |
| PBT Margin (%) | 0.16 | 10.98 | 10.37 |
| Net PROFIT Margin (%) | 0.09 | 7.75 | 10.04 |
| Return On Networth / Equity (%) | 0.05 | 4.77 | 8.31 |
| Return On Networth /Employed (%) | 0.25 | 6.90 | 7.48 |
| Return On Assets (%) | 0.04 | 4.11 | 6.43 |
| Total Debt / Equity (X) | 0.04 | 0.15 | 0.30 |
| Asset Turnover Ratio (%) | 0.49 | 0.53 | 0.64 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 8.07 |
| PBIT Margin (%) | 0.52 |
| PBT Margin (%) | 0.16 |
| Net PROFIT Margin (%) | 0.09 |
| Return On Networth / Equity (%) | 0.05 |
| Return On Networth /Employed (%) | 0.25 |
| Return On Assets (%) | 0.04 |
| Total Debt / Equity (X) | 0.04 |
| Asset Turnover Ratio (%) | 0.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 531.44 | 430.48 | 196.22 |
| Total Current Assets Annual | 251.52 | 293.61 | 307.61 |
| Non Current Assets Annual | 571.29 | 521.46 | 447.25 |
| Total Shareholders Funds Annual | 721.31 | 725.88 | 504.78 |
| Total Assets Annual | 822.80 | 815.07 | 754.86 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 531.44 |
| Total Current Assets Annual | 251.52 |
| Non Current Assets Annual | 571.29 |
| Total Shareholders Funds Annual | 721.31 |
| Total Assets Annual | 822.80 |
EPS (INR)
Expected
2.84
Reported
2.84
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
